Login / Signup
Efficacy and Safety Evaluation of 177Lu-FAP-2286 in the Treatment of Advanced Lung Cancer.
Yang Xie
Jiao Ma
Wenxin Tang
Yu Zhang
Chunyin Zhang
Yue Chen
Published in:
Clinical nuclear medicine (2024)
177Lu-FAP-2286 has the potential to be a viable PTRT option for patients with advanced lung cancer.
Keyphrases
</>
combination therapy
climate change
replacement therapy